Pancreatic adenocarcinoma: MDCT versus MRI in the detection and assessment of locoregional extension
- PMID: 16845288
- DOI: 10.1097/00004728-200607000-00006
Pancreatic adenocarcinoma: MDCT versus MRI in the detection and assessment of locoregional extension
Abstract
Purpose: To compare dynamic-contrast enhanced multirow detector computed tomography (MDCT) including multiplanar reformatted images (MPR) and magnetic resonance imaging (MRI) including magnetic resonance cholangiopancreatography images for the detection and assessment of locoregional extension of pancreatic adenocarcinoma.
Materials and methods: Twenty-four patients with and 21 patients without pancreatic adenocarcinoma underwent triple-phase MDCT and MRI. Three radiologists independently attempted to detect pancreatic adenocarcinoma and assess locoregional extension in 3 sessions. First session involved MDCT images. In the second session, radiologists had access to coronal and sagittal MPR images together with the axial images (MDCT + MPR). Third session involved MR images. Results were compared with surgical findings using receiver operating characteristic analysis and kappa statistics.
Results: Regarding tumor detection, MDCT + MPR had a significantly higher value for areas under the curve (0.96 +/- 0.02) at receiver operating characteristic analysis compared with those of MRI (0.90 +/- 0.03) and MDCT (0.85 +/- 0.04). MDCT + MPR had the highest mean sensitivity (96%), and MRI had the highest mean specificity (98%). For locoregional extension, MDCT + MPR showed the highest kappa values of the study for all factors evaluated (range, 0.63-0.86).
Conclusions: In conclusion, multiphasic MDCT imaging with MPR images was superior to multiphasic MDCT imaging without MPR images and to comprehensive MRI employing 2-D sequences and magnetic resonance cholangiopancreatography for both the detection and assessment of locoregional extension of pancreatic adenocarcinomas. MRI might be used for further lesion characterization regarding its high specificity.
Similar articles
-
MDCT of pancreatic adenocarcinoma: optimal imaging phases and multiplanar reformatted imaging.AJR Am J Roentgenol. 2006 Dec;187(6):1513-20. doi: 10.2214/AJR.05.1031. AJR Am J Roentgenol. 2006. PMID: 17114545
-
Preoperative evaluation of pancreatic cancer: comparison of gadolinium-enhanced dynamic MRI with MR cholangiopancreatography versus MDCT.J Magn Reson Imaging. 2009 Sep;30(3):586-95. doi: 10.1002/jmri.21889. J Magn Reson Imaging. 2009. PMID: 19711405
-
Usefulness of the long-axis and short-axis reformatted images of multidetector-row CT in evaluating T-factor of the surgically resected pancreaticobiliary malignancies.Eur J Radiol. 2007 Jul;63(1):96-104. doi: 10.1016/j.ejrad.2007.01.022. Epub 2007 Mar 26. Eur J Radiol. 2007. PMID: 17368790
-
Pancreatic adenocarcinoma: diagnosis and staging using multidetector-row computed tomography (MDCT) and magnetic resonance imaging (MRI).Cancer Imaging. 2007 Oct 1;7 Spec No A(Special issue A):S160-5. doi: 10.1102/1470-7330.2007.9010. Cancer Imaging. 2007. PMID: 17921087 Free PMC article. Review.
-
Pancreatic adenocarcinoma: cross-sectional imaging techniques.Abdom Radiol (NY). 2018 Feb;43(2):253-263. doi: 10.1007/s00261-017-1380-4. Abdom Radiol (NY). 2018. PMID: 29128993 Review.
Cited by
-
Comparison between multislice CT and MR imaging in the diagnostic evaluation of patients with pancreatic masses.Radiol Med. 2010 Apr;115(3):453-66. doi: 10.1007/s11547-010-0490-7. Epub 2010 Jan 15. Radiol Med. 2010. PMID: 20077047 English, Italian.
-
Differentiation of noncalculous periampullary obstruction: comparison of CT with negative-contrast CT cholangiopancreatography versus MRI with MR cholangiopancreatography.Eur Radiol. 2015 Feb;25(2):391-401. doi: 10.1007/s00330-014-3430-4. Epub 2014 Sep 24. Eur Radiol. 2015. PMID: 25249314
-
CA724 is a novel factor for predicting the unresectability in pancreatic adenocarcinoma.Int J Clin Exp Pathol. 2015 Nov 1;8(11):15112-7. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26823852 Free PMC article.
-
Radiologists' Expectations of Artificial Intelligence in Pancreatic Cancer Imaging: How Good Is Good Enough?J Comput Assist Tomogr. 2023 Nov-Dec 01;47(6):845-849. doi: 10.1097/RCT.0000000000001503. Epub 2023 Jul 28. J Comput Assist Tomogr. 2023. PMID: 37948357 Free PMC article.
-
Diagnostic accuracy of different imaging modalities following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer.Cochrane Database Syst Rev. 2016 Sep 15;9(9):CD011515. doi: 10.1002/14651858.CD011515.pub2. Cochrane Database Syst Rev. 2016. PMID: 27631326 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical